Related Experiment Video
Updated: Aug 11, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation
J Klefstrom1, E Arighi, T Littlewood
1Molecular/Cancer Biology Laboratory, Haartman Institute, PO Box 21, 00014 University of Helsinki, Finland.
Abstract:
Normal fibroblasts are resistant to the cytotoxic action of tumor necrosis factor (TNF), but are rendered TNF-sensitive upon deregulation of c-Myc. To assess if oncoproteins induce the cytotoxic TNF activity by modulating TNF signaling, we investigated the TNF-elicited signaling responses in fibroblasts containing a conditionally active c-Myc protein. In association with cell death, c-Myc impaired TNF-induced activation of phospholipase A2, JNK protein kinase and cell survival-signaling-associated NF-kappaB transcription factor complex. The TNF-induced death of mouse primary fibroblasts expressing deregulated c-Myc was inhibited by transient overexpression of the p65 subunit of NF-kappaB, which increased NF-kappaB activity in the cells. Unlike other TNF-induced signals, TNF-induced accumulation of the wild-type p53 mRNA and protein was not inhibited by c-Myc. TNF, with c-Myc, induced apoptosis in mouse primary fibroblasts but only weakly in p53-deficient primary fibroblasts. The C-terminal domain of p53, which is a transacting dominant inhibitor of wild-type p53, failed to inhibit apoptosis by c-Myc and TNF, suggesting that the cell death was not dependent on the transcription-activating function of p53. Taken together, the present findings show that the cytotoxic activity of TNF towards oncoprotein-expressing cells involves p53 and an impaired signaling for survival in such cells.
Insights
Deregulation of c-Myc makes normal cells sensitive to tumor necrosis factor (TNF)-induced death. This involves impaired cell survival signaling and p53, highlighting a new mechanism for cancer therapy.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Normal fibroblasts resist tumor necrosis factor (TNF)-induced cell death.
- Oncoproteins, such as c-Myc, can alter cellular responses to TNF.
- Understanding how oncoproteins modulate TNF signaling is crucial for cancer research.
Purpose of the Study:
- To investigate how deregulated c-Myc affects TNF-induced signaling pathways.
- To determine the role of c-Myc in TNF-mediated cytotoxicity.
- To elucidate the involvement of p53 in c-Myc and TNF-induced apoptosis.
Main Methods:
- Utilized fibroblasts with conditionally active c-Myc.
- Analyzed TNF-elicited signaling responses, including phospholipase A2, JNK, and NF-kappaB activation.
- Assessed apoptosis in wild-type and p53-deficient fibroblasts.
Main Results:
- c-Myc impaired TNF-induced activation of survival pathways (PLA2, JNK, NF-kappaB).
- Overexpression of NF-kappaB p65 inhibited TNF-induced cell death in c-Myc expressing cells.
- TNF and c-Myc induced apoptosis, dependent on p53, but not its transcriptional activity.
Conclusions:
- Cytotoxic TNF activity in oncoprotein-expressing cells involves p53.
- Impaired cell survival signaling contributes to TNF-induced cell death in the presence of c-Myc.
- Targeting these pathways could offer novel therapeutic strategies for cancers with c-Myc deregulation.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Induced Pluripotent Stem Cells
Somatic cells are...

